Fractyl Health, Inc. (GUTS) vs OS Therapies Incorporated (OSTX)

Fractyl Health, Inc. and OS Therapies Incorporated are both Biotechnology companies. Fractyl Health, Inc. and OS Therapies Incorporated are of similar size ($77.7M and $76.4M). Across the 8 metrics below, OS Therapies Incorporated leads on 5 and Fractyl Health, Inc. on 3.

Valuation

Metric GUTS OSTX Biotechnology median
P/E n/m n/m 7.88
P/S 835.89 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 656.39 n/m 10.73
Earnings yield (179.59%) (65.66%) (28.84%)
Free cash flow yield (106.75%) (25.43%) (23.03%)

Profitability

Metric GUTS OSTX Biotechnology median
Gross margin 46.24% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% 1,129.52% (57.72%)
Return on assets (146.75%) (389.65%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS OSTX Biotechnology median
Revenue growth (TTM) (22.50%) — 5.64%
EPS growth (last fiscal year) (14.81%) 23.32% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric GUTS OSTX Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 0.18 4.73
Net debt to EBITDA 0.53 0.01 0.96

Dividend

Metric GUTS OSTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric GUTS OSTX Biotechnology median
Market cap 76.41m 77.70m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack